SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-065274
Filing Date
2023-08-10
Accepted
2023-08-10 08:15:59
Documents
13
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183237-8k_moonlake.htm   iXBRL 8-K 26380
2 PRESS RELEASE, DATED AUGUST 10, 2023 ea183237ex99-1_moonlake.htm EX-99.1 88053
  Complete submission text file 0001213900-23-065274.txt   302440

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mltx-20230810.xsd EX-101.SCH 2965
4 XBRL LABEL FILE mltx-20230810_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE mltx-20230810_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea183237-8k_moonlake_htm.xml XML 3585
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 231157280
SIC: 2834 Pharmaceutical Preparations